Willow Street Advisors’s AbbVie ABBV Stock Holding History

Willow Street Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$1.01M	Buy	19,075 +4,200	+28%	+$206K	0.56%	59
2013 Q3	$665K	Hold	14,875	–	–	0.41%	67
2013 Q2	$615K	Buy	+14,875	New	+$651K	0.4%	71

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Willow Street Advisors's ABBV Position: Q4 2013 in Review

Willow Street Advisors increased its AbbVie (ABBV) stake by 28% in Q4 2013, buying an estimated $206K and bringing the position to 19,075 shares worth $1.01M. The position accounts for 0.56% of the portfolio, ranked #59.

Willow Street Advisors first reported a position in ABBV in Q2 2013 and has held it in 3 quarters since. 1,433 funds tracked by Wall St. Rank hold ABBV as of Q4 2013.

Willow Street Advisors held 19,075 shares of AbbVie worth $1.01M as of Q4 2013.
Willow Street Advisors bought 4,200 AbbVie shares in Q4 2013, an estimated $206K.
AbbVie made up 0.56% of Willow Street Advisors's portfolio in Q4 2013, its #59 holding.
Willow Street Advisors first reported a position in AbbVie in Q2 2013 and has held it in 3 quarters since.
1,433 funds tracked by Wall St. Rank held AbbVie as of Q4 2013.

Based on Willow Street Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.